159.Shimizu H, Seiki T, Asada M, Yoshimatsu K, and Koyama N. Alpha6beta1integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells.Oncogene, 2003;22: 831–839.157.Chung J, Yoon S, Datta K, Bachelder RE, and Mercurio AM. Hypoxia-inducedvascular endothelial growth factor transcription and protection from apoptosisare dependent on alpha6beta1 integrin in breast carcinoma cells. Cancer Res,2004;64: 4711–4716.134Shevde and King
163.Harms JF, Welch DR, Samant RS, Shevde LA, Miele ME, Babu GR, GoldbergSF, Gilman VR, Sosnowski DM, Campo DA, Gay CV, Budgeon LR, MercerR, Jewell J, Mastro AM, Donahue HJ, Erin N, Debies MT, Meehan WJ, JonesAL, Mbalaviele G, Nickols A, Christensen ND, Melly R, Beck LN, Kent J,Rader RK, Kotyk JJ, Pagel MD, Westlin WF, and Griggs DW. A smallmolecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435skeletal metastasis. Clin Exp Metastasis, 2004;21: 119–128.164.Alford D, Pitha-Rowe P, and Taylor-Papadimitriou J. Adhesion molecules inbreast cancer: role of alpha 2 beta 1 integrin. Biochem Soc Symp, 1998;63:245–259.165.Gui GP, Wells CA, Browne PD, Yeomans P, Jordan S Puddefoot JR, VinsonGP, and Carpenter R. Integrin expression in primary breast cancer and its166.Gui GP, Wells CA, Yeomans P, Jordan SE, Vinson GP, and Carpenter R.Integrin expression in breast cancer cytology: a novel predictor of axillarymetastasis. Eur J Surg Oncol, 1996;22: 254–258.167.Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, andBissell MJ. Reversion of the malignant phenotype of human breast cells inthree-dimensional culture and in vivo by integrin blocking antibodies. J CellBiol, 1997;137: 231–245.168.Weaver VM. and Bissell MJ. Functional culture models to study mechanismsgoverning apoptosis in normal and malignant mammary epithelial cells. JMammary Gland Biol Neoplasia, 1999;4: 193–201.169.Lipscomb EA, Simpson KJ, Lyle SR, Ring JE, Dugan AS, and Mercurio AM.The alpha6beta4 integrin maintains the survival of human breast carcinomacells in vivo. Cancer Res, 2005;65: 10970–10976.170.Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, andGiancotti FG. Beta 4 integrin amplifies ErbB2 signaling to promote mammarytumorigenesis. Cell, 2006;126: 489–502.relation to axillary nodal status. Surgery, 1995;117: 102–108.171.Spangenberg C, Lausch EU, Trost TM, Prawitt D, May A, Keppler R, Fees SA,Reutzel D, Bell C, Schmitt S, Schiffer IB, Weber A, Brenner W, Hermes M,Sahin U, Tureci O, Koelbl H, Hengstler JG, and Zabel BU. ERBB2-mediatedtranscriptional up-regulation of the alpha5beta1 integrin fibronectin receptorpromotes tumor cell survival under adverse conditions. Cancer Res, 2006;66:3715–3725.176.Gilcrease MZ, Zhou X, and Welch K. Adhesion-independent alpha6beta4integrin clustering is mediated by phosphatidylinositol 3-kinase. Cancer Res,2004;64: 7395–7398.177.Litvinov SV, Bakker HA, Gourevitch MM, Velders MP, and Warnaar SO.Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelialcell-cell adhesion. Cell Adhes Commun, 1994;2: 417–428.
Upload your study docs or become a
Course Hero member to access this document
Upload your study docs or become a
Course Hero member to access this document
End of preview. Want to read all 439 pages?
Upload your study docs or become a
Course Hero member to access this document
